Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Foot Ulcer Due to Type 1 Diabetes Mellitus: later-stage trial registry
2 of 2 indexed Foot Ulcer Due to Type 1 Diabetes Mellitus trials are currently recruiting, with more weight in Phase 3-4.
Corpus placement: #7,188 of 28,707 conditions by registered trial count.
2 US clinical trials · 2 currently recruiting · #7,188 of 28,707 conditions by registered trial count
Foot Ulcer Due to Type 1 Diabetes Mellitus: 2 US clinical trials tracked, 2 recruiting.
Foot Ulcer Due to Type 1 Diabetes Mellitus is the subject of 2 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Applied Biologics, running 1 of these trials.
Enrollment posture brief
Registry condition foot-ulcer-due-to-type-1-diabetes-mellitus
OPEN 2 | RECR 100% | LATE 2 | EARLY 0 | RANK #7188 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)
Foot Ulcer Due to Type 1 Diabetes Mellitus lists 2 open slots (100% of 2 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Foot Ulcer Due to Type 1 Diabetes Mellitus on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Foot Ulcer Due to Type 1 Diabetes Mellitus is recruiting above its size-band peers.
2 of 2 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
2 total, page 1 of 1
Randomized Evaluation of Nonhealing Diabetic Foot Ulcers With Exclusive Wound Therapy
Sequence LifeScience
NCT07086443
A Multicenter, Prospective, Controlled Clinical Trial Evaluating the Efficacy of a Single Layer Placental-based Allograft and Standard of Care in the Management of Nonhealing Diabetic Foot Ulcers
Applied Biologics
NCT07159282
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 4 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Foot Ulcer Due to Type 1 Diabetes Mellitus records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Foot Ulcer Due to Type 1 Diabetes Mellitus trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Foot Ulcer Due to Type 1 Diabetes Mellitus page
2 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 Foot Ulcer Due to Type 1 Diabetes Mellitus trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Applied Biologics sponsors the most Foot Ulcer Due to Type 1 Diabetes Mellitus trials on record, review their full trial history before evaluating a specific study. See Applied Biologics's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Foot Ulcer Due to Type 1 Diabetes Mellitus condition card totals 2 registered trials; most-linked intervention XWRAP; top US site state Pennsylvania. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.